Andere talen Certara, Inc.

Aandelen

CERT

US15687V1098

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
16,3 ^USD	-0,91%		+0,56%	-7,33%

16/04	Certara, Inc. lanceert cloudplatform om zijn end-to-end wetenschappelijke softwareplatform verder te uniformiseren	CI
10/04	Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Certara Launches Cloud Platform to Unify Scientific Software Solutions	16/04
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform	16/04
Certara, Inc. Launches Cloud Platform to Further Unify Its End-To-End Scientific Software Platform	16/04
North American Morning Briefing : Stock Futures -2-	11/04
Sector Update: Health Care Stocks Slipping Late Afternoon	10/04
Certara Poised to Benefit From Improving End Markets, KeyBanc Says	10/04
North American Morning Briefing : Traders Await -2-	10/04
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference	09/04
Certara Shares Rise After JMP Securities Starts Coverage at Market Perform	04/04
Certera Adjusted EPS Declines, Revenue Climbs; Shares Fall After Hours	29/02
Certara, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Certara, Inc. Provides Earnings Guidance for the Year 2024	29/02
Certara, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Earnings Flash (CERT) CERTARA Posts Q4 EPS $0.09, vs. Street Est of $0.11	29/02
Earnings Flash (CERT) CERTARA Reports Q4 Revenue $88M, vs. Street Est of $86.7M	29/02
Certara Reports Fourth Quarter 2023 Financial Results	29/02
Certara Reports Fourth Quarter 2023 Financial Results	29/02
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference	01/02
Certara Acquires Applied BioMath to Expand Biosimulation Capabilities	13/12
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies	13/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Certara, Inc.

Aandelen

CERT

US15687V1098

Andere talen

Filters